Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow Inc. demonstrated a strong performance in 3Q25, with revenues reaching $46.3 million—a 41% year-over-year increase—driven primarily by the uptake of its FFR-CT coronary disease analysis software. Gross margins impressively improved to 76.8%, indicating enhanced profitability and operational efficiency. Additionally, the fundamentals of the core business are solid, as evidenced by robust volume growth, expanding adoption of coronary CT angiography, and the anticipation of future revenue contributions from plaque analysis, positioning the company for sustained mid-20s revenue growth moving forward.

Bears say

HeartFlow Inc has sustained substantial net losses since its inception, with $95.7 million in FY23 and $96.4 million in FY24, contributing to an uncertain profitability outlook as the company anticipates incurring further losses moving forward. The adoption of HeartFlow's diagnostic technology is contingent upon healthcare providers adhering to specific guidelines from the ACC and AHA, which may not be universally adopted. Additionally, the company faces reimbursement risks; inadequate coverage from third-party payors could significantly hinder the adoption of its platform, thus adversely impacting its financial position and growth prospects.

HeartFlow Inc (HTFL) has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 5 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $38.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $38.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.